We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 10
Most popular |Most recent


The Last Two Years: A Summary of 2014-2015 Office of Prescription Drug Promotion (OPDP) Enforcement and Relevant FDA Guidance

USA - March 1 2016 The past two years have created a bit of uncertainty for life sciences promotional review professionals. With fewer enforcement letters, high-profile...

Jennifer A. Romanski.


FDA seeks comments on proposed comparative price information study

USA - May 20 2014 In a notice published in the Federal Register on May 7, 2014, the federal Food and Drug Administration (FDA) is soliciting comments on a proposed...


OPDP Bad Ad Program absent in 2013 and first four months of 2014

USA - April 30 2014 On May 11, 2010, the Division of Drug Marketing, Advertising, and Communications (DDMAC), now the Office of Prescription Drug Promotion (OPDP)...


The Office of Inspector General releases 2014 Work Plan

USA - March 6 2014 The Office of Inspector General (OIG) has released its 2014 Work Plan. The Work Plan summarizes activities OIG plans to pursue with respect to the U...


Distributing scientific and medical publications on unapproved new uses is the subject of revised FDA draft guidance

USA - March 5 2014 On February 28, 2014, the U.S. Food and Drug Administration (FDA) released the revised draft guidance entitled "Distributing Scientific and Medical...